Checktor Biosciences
Z├╝rich
About Checktor Biosciences
Checktor Biosciences develops diagnostic tests for infections and antibiotic resistance. Its tests provide results in about ten minutes at the point of care, detecting both the pathogen and which antibiotics would be effective. The company uses a molecular diagnostic assay with CRISPR-based chemistry to enable rapid detection of antibiotic susceptibilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $47.6K
- Last round: Grant (Dec 2023)
- Website: checktor.bio
Canonical: https://fsome.com/organization/checktor-biosciences-162287 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.